Crypto Stocks Gain After Judge Dismisses Part of SEC's Ripple Case
By Dean Seal
Shares of companies in the cryptocurrency space are trading higher after the crypto firm Ripple Labs won early dismissal of some regulatory allegations related to its selling of $1.4 billion worth of a digital token known as XRP.
Shares of Coinbase Global, operator of the largest U.S. crypto exchange, are up 10% at $94.66 in midday trading. Shares of the digital payments group Block were up 6.3% at $75.73. Bitcoin miner Riot Platform's shares are 12% higher at $19.82. Fellow miner Marathon Digital's shares are up 12% at $18.85.
A federal judge on Thursday sided with Ripple's argument that roughly half of its sales of XRP, a token that Ripple founders developed in 2012 to facilitate cross-border payments, didn't constitute an illegal securities offering. Ripple has argued that XRP isn't a security, contrary to claims by the Securities and Exchange Commission.
The decision could be helpful to other cryptocurrency companies that are fighting similar enforcement actions by the SEC. The Wall Street regulator's case against Ripple has largely been seen as a litmus test for the agency's authority in the crypto space.
Shares of crypto miners Cleanspark and Bit Digital were up 12% each as well, at $7.38 and $4.36, respectively. Hut 8 Mining shares have climbed 14% to $4.28. The stock of Iris Energy, a sustainable bitcoin mining company, is up 12% at $7.80.
MicroStrategy, a business-intelligence software provider that has built a large position in Bitcoin, saw its shares rise 5.7% to $436.93.
Bitcoin, the largest crypto asset by market capitalization, is up 1.7% at $30,820. Other major crypto assets are trading even larger gains.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
July 13, 2023 14:01 ET (18:01 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth